Education
About Us
Working with TipRanks
Follow Us
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
Apimeds Pharmaceuticals US, Inc. (APUS) Ownership Overview
The ownership structure of Apimeds Pharmaceuticals US, Inc. (APUS) stock is a mix of institutional, retail, and individual investors. , 64.31% is owned by Insiders, and 35.32% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 15, 2025 | xxxxxxxxxxxxx | $50359 | |
May 14, 2025 | xxxxxxxxxxxxx | $772598 | |
May 14, 2025 | xxxxxxxxxxxxx | $2000000 | |
May 14, 2025 | xxxxxxxxxxxxx | $56715 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,416,365 | Insider | 51.02% | 13,025,221 | |
| 750,000 | Insider | 5.96% | 1,522,500 | |
| 643,885 | Insider | 5.12% | 1,307,087 | |
| 277,500 | Insider | 2.21% | 563,325 | |
| 34,953 | Institution | 0.28% | 70,955 | |
| 11,969 | Institution | 0.10% | 24,297 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,969 | Institution | 0.10% | 24,297 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 34,953 | Institution | 0.28% | 62,216 |
FAQ
Who Owns Apimeds Pharmaceuticals US, Inc. (APUS)?
Currently, no data Available
What percentage of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by institutional investors?
Currently, no data Available
What percentage of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.32% of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by retail investors.
Who owns the most shares of Apimeds Pharmaceuticals US, Inc. (APUS)?
Inscobee Inc. owns the most shares of Apimeds Pharmaceuticals US, Inc. (APUS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.